Carl Meisner
Family Medicine · Sugar Land, TXNPI 1184610529
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,677 of the $2,267 with a category attached, or 74.0%.
Across 27 payments — averaging $83.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$1K
- Novo Nordisk AS$1K
Across 631 payments — averaging $967.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$298K
- Eli Lilly$172K
- Bayer$85K
- Sanofi-aventis U.S. LLC$30K
- Amgen$17K
- AbbVie$6K
- plus $3K from 1 others
What the payments were for
- Travel & lodging$1,67774%
- Food & beverage$59026%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 23 | $1,183 |
| Novo Nordisk AS | 4 | $1,083 |
How this compares
$2,267 in reported general payments places this provider in the 75th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Sugar Land
- Anne Marie Ponce de LeonSugar Land$109K
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.